Literature DB >> 2959077

Intraluminal colonic levels of arachidonic acid metabolites in ulcerative colitis.

K Lauritsen1, L S Laursen, K Bukhave, J Rask-Madsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2959077

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  5 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 2.  Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease.

Authors:  A N Wadworth; A Fitton
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

3.  Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.

Authors:  K Lauritsen; L Staerk Laursen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

4.  Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion.

Authors:  T D Wardle; L Hall; L A Turnberg
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

5.  The effect of malotilate, a derivative of malotilate and a flavenoid on eicosanoid production in inflammatory bowel disease in rats.

Authors:  A P Dijk; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.